These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 9525641)
21. Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles. Schweneker M; Laimbacher AS; Zimmer G; Wagner S; Schraner EM; Wolferstätter M; Klingenberg M; Dirmeier U; Steigerwald R; Lauterbach H; Hochrein H; Chaplin P; Suter M; Hausmann J J Virol; 2017 Jun; 91(11):. PubMed ID: 28331098 [TBL] [Abstract][Full Text] [Related]
22. Single-Nucleotide Polymorphisms in Human NPC1 Influence Filovirus Entry Into Cells. Kondoh T; Letko M; Munster VJ; Manzoor R; Maruyama J; Furuyama W; Miyamoto H; Shigeno A; Fujikura D; Takadate Y; Yoshida R; Igarashi M; Feldmann H; Marzi A; Takada A J Infect Dis; 2018 Nov; 218(suppl_5):S397-S402. PubMed ID: 30010949 [TBL] [Abstract][Full Text] [Related]
23. Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1. Stitz J; Buchholz CJ; Engelstädter M; Uckert W; Bloemer U; Schmitt I; Cichutek K Virology; 2000 Jul; 273(1):16-20. PubMed ID: 10891403 [TBL] [Abstract][Full Text] [Related]
24. Shedding of Ebola Virus Surface Glycoprotein Is a Mechanism of Self-regulation of Cellular Cytotoxicity and Has a Direct Effect on Virus Infectivity. Dolnik O; Volchkova VA; Escudero-Perez B; Lawrence P; Klenk HD; Volchkov VE J Infect Dis; 2015 Oct; 212 Suppl 2():S322-8. PubMed ID: 26092855 [TBL] [Abstract][Full Text] [Related]
25. Cell-cell contact promotes Ebola virus GP-mediated infection. Miao C; Li M; Zheng YM; Cohen FS; Liu SL Virology; 2016 Jan; 488():202-15. PubMed ID: 26655238 [TBL] [Abstract][Full Text] [Related]
26. Ebola virus can be effectively neutralized by antibody produced in natural human infection. Maruyama T; Rodriguez LL; Jahrling PB; Sanchez A; Khan AS; Nichol ST; Peters CJ; Parren PW; Burton DR J Virol; 1999 Jul; 73(7):6024-30. PubMed ID: 10364354 [TBL] [Abstract][Full Text] [Related]
27. Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity. Kaletsky RL; Simmons G; Bates P J Virol; 2007 Dec; 81(24):13378-84. PubMed ID: 17928356 [TBL] [Abstract][Full Text] [Related]
28. Growth-Adaptive Mutations in the Ebola Virus Makona Glycoprotein Alter Different Steps in the Virus Entry Pathway. Ruedas JB; Arnold CE; Palacios G; Connor JH J Virol; 2018 Oct; 92(19):. PubMed ID: 30021890 [TBL] [Abstract][Full Text] [Related]
29. Characterization of the inhibitory effect of an extract of Prunella vulgaris on Ebola virus glycoprotein (GP)-mediated virus entry and infection. Zhang X; Ao Z; Bello A; Ran X; Liu S; Wigle J; Kobinger G; Yao X Antiviral Res; 2016 Mar; 127():20-31. PubMed ID: 26778707 [TBL] [Abstract][Full Text] [Related]
30. Modulation of virion incorporation of Ebolavirus glycoprotein: effects on attachment, cellular entry and neutralization. Marzi A; Wegele A; Pöhlmann S Virology; 2006 Sep; 352(2):345-56. PubMed ID: 16777170 [TBL] [Abstract][Full Text] [Related]
31. Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses. Chan SY; Speck RF; Ma MC; Goldsmith MA J Virol; 2000 May; 74(10):4933-7. PubMed ID: 10775638 [TBL] [Abstract][Full Text] [Related]
32. Two strings to the bow of Ebola virus. Klenk HD; Volchkov VE; Feldmann H Nat Med; 1998 Apr; 4(4):388-9. PubMed ID: 9546777 [No Abstract] [Full Text] [Related]
33. Murine leukemia virus pseudotypes of La Crosse and Hantaan Bunyaviruses: a system for analysis of cell tropism. Ma M; Kersten DB; Kamrud KI; Wool-Lewis RJ; Schmaljohn C; González-Scarano F Virus Res; 1999 Oct; 64(1):23-32. PubMed ID: 10500280 [TBL] [Abstract][Full Text] [Related]
34. Differential induction of cellular detachment by envelope glycoproteins of Marburg and Ebola (Zaire) viruses. Chan SY; Ma MC; Goldsmith MA J Gen Virol; 2000 Sep; 81(Pt 9):2155-2159. PubMed ID: 10950971 [TBL] [Abstract][Full Text] [Related]
35. Cyanovirin-N binds to the viral surface glycoprotein, GP1,2 and inhibits infectivity of Ebola virus. Barrientos LG; O'Keefe BR; Bray M; Sanchez A; Gronenborn AM; Boyd MR Antiviral Res; 2003 Mar; 58(1):47-56. PubMed ID: 12719006 [TBL] [Abstract][Full Text] [Related]
36. The Role of Conserved N-Linked Glycans on Ebola Virus Glycoprotein 2. Lennemann NJ; Walkner M; Berkebile AR; Patel N; Maury W J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S204-9. PubMed ID: 26038399 [TBL] [Abstract][Full Text] [Related]
37. Characterization of a Novel Neutralizing Monoclonal Antibody Against Ebola Virus GP. Reynard O; Volchkov VE J Infect Dis; 2015 Oct; 212 Suppl 2():S372-8. PubMed ID: 26232760 [TBL] [Abstract][Full Text] [Related]
38. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins. Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907 [No Abstract] [Full Text] [Related]
39. Novel Small Molecule Entry Inhibitors of Ebola Virus. Basu A; Mills DM; Mitchell D; Ndungo E; Williams JD; Herbert AS; Dye JM; Moir DT; Chandran K; Patterson JL; Rong L; Bowlin TL J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S425-34. PubMed ID: 26206510 [TBL] [Abstract][Full Text] [Related]
40. Antibody-Mediated Protective Mechanisms Induced by a Trivalent Parainfluenza Virus-Vectored Ebolavirus Vaccine. Kimble JB; Malherbe DC; Meyer M; Gunn BM; Karim MM; Ilinykh PA; Iampietro M; Mohamed KS; Negi S; Gilchuk P; Huang K; Wolf YI; Braun W; Crowe JE; Alter G; Bukreyev A J Virol; 2019 Feb; 93(4):. PubMed ID: 30518655 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]